Personal information

United Kingdom

Biography

David Goldblatt is Professor of Vaccinology and Immunology at the University College London's (UCL) GOS Institute of Child Health and a Consultant Paediatric Immunologist at the Great Ormond Street Hospital for Children NHS Foundation Trust (GOSH). He was the GOSH Director of Clinical Research and Development from 2003 to 2023 and the Inaugural Director of the National Institute for Health Research GOSH/UCL Biomedical Research Centre from 2007 till 2017. He was Deputy Director of the GOS UCL ICH from 2015 to 2023. He obtained his medical degree from the University of Cape Town, South Africa, his Paediatric qualifications from the Royal College of Physicians (London) and a PhD in Immunology from the University of London, United Kingdom.
He has a long-standing interest in the immune response to vaccines and infectious diseases. He has active research programmes exploring immunity to colonisation/ carriage and infection, correlates of protection and assessing alternative vaccines schedules. His laboratory (a WHO Reference Laboratory for Pneumococcal Serology) interests include Streptococcus Pneumoniae, Klebsiella Pneumonia, Group A and B Streptococcus and SARS-CoV-2. He is an advisor to the World Health Organisation (WHO) on vaccines including COVID and Co-chairs the recently formed WHO Technical Advisory Group on Group B Streptococcus. He serves on subcommittees of the United Kingdom Department of Health Joint Committee on Vaccines and Immunisation (JCVI), has advised the MHRA on COVID Vaccine licensure via membership of the Commission on Human Medicines COVID-19 Vaccines Benefit Risk Expert Working Group. He chairs several Scientific Advisory Boards including the International SAB advising the Malawi-Liverpool-Wellcome Trust Clinical Research Programme in Blantyre and the Immunisation HPRU at the London School of Hygiene and Tropical Medicine. He has just finished a 6 year term as President of the International Society of Pneumonia and Pneumococcal Disease.

Activities

Employment (3)

University College London: London, England, GB

Employment
Source: check_circle
University College London

Great Ormond Street Hospital for Children NHS Foundation Trust: London, London, GB

1995-08 to present | Honorary Consultant in Paediatric Immunology
Employment
Source: Self-asserted source
David Goldblatt

Great Ormond Street Hospital for Children NHS Foundation Trust: London, GB

2003-10-01 to 2023-04-09 | Director of Clinical Research and Development
Employment
Source: Self-asserted source
David Goldblatt

Education and qualifications (5)

Royal College of Physicians: London, GB

2006 to present | FRCP
Education
Source: Self-asserted source
David Goldblatt

Royal College of Paediatrics and Child Health: London, London, GB

2001 to present | FRCPCH
Education
Source: Self-asserted source
David Goldblatt

University of London: London, GB

1988-07 to 1991-06 | PhD (Institute of Child Health)
Education
Source: Self-asserted source
David Goldblatt

Royal College of Physicians: London, GB

1984 to 1986 | MRCP (UK) (Paediatrics)
Education
Source: Self-asserted source
David Goldblatt

University of Cape Town: Rondebosch, ZA

1978-01 to 1983-12 | MB ChB (Medicine)
Education
Source: Self-asserted source
David Goldblatt

Professional activities (6)

University of the Witwatersrand: Johannesburg, ZA

Chairperson, Scientific Advisory Committee (African Local Initiative for Vaccinology Expertise (ALIVE))
Invited position
Source: Self-asserted source
David Goldblatt

International Society of Pneumonia and Pneumococcal Disease: Geneva, CH

(President )
Distinction
Source: Self-asserted source
David Goldblatt

World Health Organization: Geneva, CH

2022 to present | Chairperson (Technical Advisory Group on Group B Streptococcus Vaccine Development (TAG-GBS))
Invited position
Source: Self-asserted source
David Goldblatt

New Zealand Ministry of Health Group A Streptococcus Vaccine Initiative: Auckand, NZ

2022 to present | Advisory Board Committee Member (New Zealand Ministry of Health Group A Streptococcus Vaccine Initiative)
Invited position
Source: Self-asserted source
David Goldblatt

World Health Organization: Geneva, CH

2021 to present | Vice Chairperson (Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC) )
Invited position
Source: Self-asserted source
David Goldblatt

Malawi-Liverpool-Wellcome Trust Clinical Research Programme: Blantyre, MW

2016 to present | Chairperson ( Scientific Advisory Board)
Invited position
Source: Self-asserted source
David Goldblatt

Funding (1)

NIHR Great Ormond Street Biomedical Research Centre

2007-04-01 to 2012-03-31 | Grant
NIHR Central Commissioning Facility (London, GB)
GRANT_NUMBER: ormbrc-2007-1
Source: Self-asserted source
David Goldblatt via DimensionsWizard

Peer review (7 reviews for 4 publications/grants)

Review activity for Genome medicine. (1)
Review activity for Nature medicine. (1)
Review activity for npj vaccines. (1)
Review activity for Vaccine. (4)